跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 37,151 条关于
“IDH-mutant low-grade gliomas”
全部
37,151
临床试验
27,280
药物
814
机构
109
资讯
8,948
2个月前
Vorasidenib Offers Targeted Treatment for IDH-Mutant Low-Grade Gliomas
3年前
Vorasidenib Shows Promise as First Targeted Therapy for IDH-Mutant Low-Grade Gliomas
去年
Critical Review Questions Vorasidenib's Role in Low-Grade Glioma Treatment
11个月前
NICE Rejects Vorasidenib for NHS Use Despite Positive Brain Cancer Trial Results
去年
FDA Approves Vorasidenib as Targeted Therapy for IDH-Mutant Gliomas
去年
Vorasidenib Shows Sustained Benefit in IDH-Mutant Low-Grade Glioma
10个月前
Vorasidenib Demonstrates Sustained Long-Term Efficacy in IDH-Mutant Grade 2 Glioma
2年前
FDA Approves Vorasidenib (Voranigo) for IDH-Mutant Grade 2 Glioma
去年
European Regulators Recommend Approval of Vorasidenib for IDH-Mutant Grade 2 Glioma
9个月前
FDA Grants Fast Track Designation to Zotiraciclib for IDH-Mutant Recurrent High-Grade Glioma
第 1 页，共 895 页
上一页
下一页
